<SEC-DOCUMENT>0001437749-23-007711.txt : 20230324
<SEC-HEADER>0001437749-23-007711.hdr.sgml : 20230324
<ACCEPTANCE-DATETIME>20230324090056
ACCESSION NUMBER:		0001437749-23-007711
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230323
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230324
DATE AS OF CHANGE:		20230324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39563
		FILM NUMBER:		23757840

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			GA
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			GA
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>govx20230323_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:govx="http://www.govx.com/20230323"><head>
	<title>govx20230323_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 3/23/2023 10:33:03 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20238K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20238K" name="dei:EntityCentralIndexKey">0000832489</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="govx-20230323.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20238K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000832489</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-03-23</xbrli:startDate>
<xbrli:endDate>2023-03-23</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000832489</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:CommonStockParValue0001PerShareCustomMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-03-23</xbrli:startDate>
<xbrli:endDate>2023-03-23</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000832489</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:WarrantsToPurchaseCommonStockCustomMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-03-23</xbrli:startDate>
<xbrli:endDate>2023-03-23</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>WASHINGTON, D.C. 20549</b>&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#xa0;</div>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; font-variant: normal; text-align: center; margin: 0pt;"><b>FORM <ix:nonNumeric contextRef="d20238K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Pursuant to Section 13 or 15(d) of the</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Date of report (Date of earliest event reported):</b>&#xa0;&#xa0;<ix:nonNumeric contextRef="d20238K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b>March 23, 2023</b></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;</div>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityRegistrantName"><b>GEOVAX LABS, INC.</b></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Exact name of registrant as specified in its charter)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td style="vertical-align:top;width:14.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Delaware</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:14.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityFileNumber"><b>001-39563</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:14.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityTaxIdentificationNumber"><b>87-0455038</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:14.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(State or other jurisdiction of</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>incorporation or organization)</b></div>
			</td>
			<td style="vertical-align:bottom;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:14.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Commission File No.)</b></div>
			</td>
			<td style="vertical-align:bottom;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:14.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(IRS Employee Identification No.)</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressAddressLine1"><b>1900 Lake Park Drive, Suite 380</b></ix:nonNumeric></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressCityOrTown"><b>Smyrna</b></ix:nonNumeric><b>, <ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince"><b>Georgia</b></ix:nonNumeric> <ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressPostalZipCode"><b>30080</b></ix:nonNumeric></b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Address of principal executive offices) (Zip code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(<ix:nonNumeric contextRef="d20238K" name="dei:CityAreaCode"><b>678</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20238K" name="dei:LocalPhoneNumber"><b>384-7220</b></ix:nonNumeric></b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Registrant</b>&#8217;<b>s telephone number, including area code)</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13(e)-4(c))</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Title of each class</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Trading</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Symbol(s)</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:8.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare" name="dei:TradingSymbol">GOVX</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Capital Market</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock" name="dei:Security12bTitle">Warrants to Purchase Common Stock</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:8.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock" name="dei:TradingSymbol">GOVXW</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:18.8%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Capital Market</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Section 240.12b-2 of this chapter).</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Emerging growth company <ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial reporting standards provided pursuant to Section&#xa0;13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
1

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Forward-Looking Statements</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">This Current Report on Form 8-K and other reports filed by the Company from time to time with the Securities and Exchange Commission (collectively the &#8220;Filings&#8221;) contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company&#8217;s management as well as estimates and assumptions made by the Company&#8217;s management. When used in the Filings the words &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;future&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221; or the negative of these terms and similar expressions as they relate to the Company or the Company&#8217;s management identify forward looking statements.&#xa0;&#xa0;Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the Company&#8217;s industry, operations and results of operations and any businesses that may be acquired by the Company. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned. Except as required by law, the Company does not undertake to update its forward-looking statements.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Item 2.02 </b></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Results of Operations and Financial Condition.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On March 23, 2023, GeoVax Labs, Inc. (the &#8220;Company&#8221;) issued a press release reporting its results of operations for the year ended December 31, 2022. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 63pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Item 9.01 </b></div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>Financial Statements and Exhibits.</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">(d)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;Exhibits</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:5.5%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><span style="text-decoration: underline;">Exhibit No.</span></div>
			</td>
			<td style="vertical-align:top;width:40.2%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><span style="text-decoration: underline;">Description</span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5.5%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">99.1</div>
			</td>
			<td style="vertical-align:top;width:40.2%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><a href="ex_492481.htm" style="-sec-extract:exhibit;">Press Release dated March 23, 2023</a></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:5.5%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">104</div>
			</td>
			<td style="vertical-align:top;width:40.2%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
2

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>SIGNATURE</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">Date: March 24, 2023</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:17.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">GEOVAX LABS, INC.</div>
			</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:17.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:17.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.4%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Mark W. Reynolds</div>
			</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.4%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:16%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark W. Reynolds</div>
			</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:16%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</div>
			</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:22.8%;">&#xa0;</td>
			<td style="vertical-align:top;width:1.4%;">&#xa0;</td>
			<td style="vertical-align:top;width:16%;">&#xa0;</td>
			<td style="vertical-align:top;width:5.4%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
3
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex_492481.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_492481.htm</title>

	<!-- Generated by ThunderDome Portal - 3/23/2023 10:36:22 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin: 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<div><img alt="logo01.jpg" src="logo01.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>GeoVax Reports 2022 Year-End Financial Results</b></p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>And Provides Corporate Update</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>Company Expands Ongoing Clinical Trials and the</i></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>Breadth and Capacity of Its Novel Vaccine Platform Technology</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Atlanta, GA, March 23, 2023</b> &#8211; GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced its financial results and key operational accomplishments for the year ended December 31, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">GeoVax&#8217;s leadership will host a live conference call and webcast at 4:30 p.m. Eastern Time today, March 23, 2023, to discuss financial results and provide a general business update. Details are provided below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>2022 CLINICAL TRIAL PROGRESS AND OPERATIONAL DEVELOPMENTS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;Our corporate focus continues to be on the advancement of our ongoing clinical programs for our novel Gedeptin&#174;<sup style="vertical-align:top;line-height:120%;font-size:pt"> </sup>cancer therapy targeting advanced head &amp; neck cancers and, our SARS-CoV-2/Covid19 vaccine, stated David Dodd, GeoVax&#8217;s Chairman and CEO. &#8220;To that end, we have expanded to additional clinical sites and are accelerating patient enrollment for both programs, as noted in this update. We look forward to reporting milestone progress on these trials during the remainder of 2023.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Dodd continued, &#8220;We are also delighted to have advanced our GeoVax MVA-VLP-MUC1 immuno-oncology candidate into IND-supportive studies. Thus far, the results from these studies are encouraging. We also secured rights to NIH-MVA technology for further development and commercial use against Monkeypox (MPox) and Smallpox viruses, which provides a compelling opportunity to leverage our MVA-based vaccine expertise and help expand the global public health supply options available for this ongoing worldwide public health threat. Our intent is to be the first U.S.-based, primary supplier of a MVA-vaccine against Mpox and Smallpox.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Dodd concluded, &#8220;We recently announced important progress toward developing a high-yield, high-capacity, avian cell line system for manufacturing MVA-based vaccines. Developing such a process will be nothing short of transformational &#8211; for GeoVax, biomedicine, and public health worldwide. By advancing our MVA manufacturing to a modern, interchangeable process, we are on course to expand MVA applications from stockpile-based solutions for niche medical markets to have the capability to respond to world needs on a timely basis. This well positions us to potentially become the first US-based supplier of the MVA vaccine to prevent MPox, Smallpox, and other pox-related viruses. Finally, during a very difficult year for biotech capital development, with many companies furloughing programs and staff, GeoVax successfully strengthened our capital base in support of expanding and accelerating our growth and development programs. We have entered 2023 well positioned and capable of achieving our clinical and other business goals and milestones.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>GEDEPTIN</u></b><u>&#174;</u><b><u> FOR ADVANCED HEAD AND NECK CANCER </u></b><u>&#8211;</u><b><u> PHASE 2 TRIAL EXPANSION</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">An ongoing Phase 1/2 trial (ClinicalTrials.gov Identifier: <u>NCT03754933</u>) is evaluating the safety and efficacy of repeat cycles of Gedeptin&#174; therapy in patients with recurrent head and neck squamous cell carcinoma (HNSCC), with tumor(s) accessible for injection and no curable treatment options.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Gedeptin&#174; is a novel patented product/technology for the treatment of solid tumors through a gene therapy strategy known as Gene-Directed Enzyme Prodrug Therapy (GDEPT). In GDEPT, a vector is used to selectively transduce tumor cells with a nonhuman gene, which expresses an enzyme that can convert a nontoxic prodrug into a very toxic antitumor compound <i>in situ</i>. A Phase 1 dose-ranging study, evaluating the safety of a single cycle of Gedeptin&#174; therapy, found the therapy well-tolerated, with evidence of a reduction in tumor size in patients with solid tumors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In February 2023, GeoVax announced the expansion of the Gedeptin&#174; Phase 1/2 trial with patients actively enrolling at National Cancer Institute (NCI) designated Cancer Centers &#8211; Stanford University Cancer Institute, Emory University Winship Cancer Institute, and the Thomas Jefferson University Sidney Kimmel Cancer Center. Funded in part by the US Food &amp; Drug Administration (FDA) under its Orphan Products Clinical Trials Grants Program, the trial will guide the design of a larger study that also may involve patients with other anatomically accessible oral and pharyngeal cancers. Additionally, it may lead to labeling discussions with the FDA and initiation of further Gedeptin&#174; investigations, including in combination with immune checkpoint inhibitors for other cancerous and non-cancerous tumor indications.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM"><b>MORE</b></div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>SARS-CoV-2 VACCINES </u></b><u>&#8211;</u><b><u> TWO PHASE 2 CLINICAL TRIALS PROGRESSING</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">GEO-CM04S1 is a next-generation Covid-19 vaccine that expresses spike and nucleocapsid antigens of the SARS-CoV-2 (COVID-19) virus. GEO-CM04S1 continues to advance in two Phase 2 clinical studies, one as a primary vaccine for immunocompromised cancer patients, in direct comparison to either the Pfizer or Moderna mRNA vaccine (ClinicalTrials.gov Identifier: <u>NCT04977024</u>), and the second as a booster for healthy patients who have previously received either the Pfizer or Moderna vaccine as their initial inoculation (ClinicalTrials.gov Identifier: <u>NCT04639466</u>).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Two 2022 peer-reviewed publications in The Lancet Microbe (accessible <u>here</u>) and iScience (accessible <u>here</u>) report data from the Phase 1 study of GEO-CM04S1 showing robust neutralizing antibodies and T cells against SARS-CoV-2, including the Omicron and Delta variants. These data confirm the powerful dual action of the GeoVax vaccine, an important feature given the multiple mutations, leading to variants of concern and inconsistent protection from existing FDA-authorized vaccines. These findings suggest that T cell immunity stimulated by GEO-CM04S1 may constitute a critical second line of defense to provide long-term protection against SARS-CoV-2 variants among the population in general as well as among the 15 million patients in the US with compromised immune systems. Additionally, a recent article, published in the New England Journal of Medicine (accessible <u>here</u>) addressed the critical importance of addressing both antibodies and T cells in achieving protection against SARS-CoV-2.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>MODIFIED VACCINIA ANKARA (MVA) &amp; MONKEYPOX (MPOX)</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">MVA is the vaccine currently used and stockpiled in the US Strategic National Stockpile for immunization against the MPox and Smallpox viruses. GeoVax previously demonstrated that an experimental HIV vaccine, utilizing NIH-MVA as the vaccine vector, protected non-human primates challenged with a lethal dose of the MPox virus (publication accessible <u>here</u>). Further, in August 2022, City of Hope, which originally developed GEO-CM04S1, published results demonstrating that both their proprietary sMVA (synthetic MVA) and GEO-CM04S1 (referred to as &#8220;COH04S1&#8221; in the publication, accessible <u>here</u>) elicited robust orthopoxvirus-specific binding and neutralizing antibody responses. The authors conclude that GEO-CM04S1 and sMVA represent unique vaccine candidates to control the unforeseen global MPox outbreak.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In response to the global need to address the continued emerging threat from MPox and the unique opportunity offered by MVA-based vaccines, GeoVax secured rights from the NIH covering preclinical, clinical and commercial uses of the NIH-MVA against MPox or Smallpox viruses. The Company is now evaluating development and regulatory pathways towards expanding the public health options available to reduce and manage the risk of MPox worldwide with the intent to be the first U.S.-based supplier of a MVA-vaccine against MPox and Smallpox.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>MVA MANUFACTURING PROCESS DEVELOPMENTS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In February 2023, GeoVax announced significant progress in developing a high-yield, high-capacity, continuous avian cell line system for manufacturing its MVA-based vaccines and immunotherapies. Currently, MVA vaccines are manufactured in cells cultured from chicken embryonic fibroblasts (CEF), a suboptimal and time-consuming process useful primarily for niche markets and stockpile reserves. Now, after exploring various approaches to growing MVA in continuous cell lines in bioreactors more suitable for high-yield, commercial-scale manufacturing, GeoVax will accelerate activities towards fully implementing a proprietary, continuous cell line manufacturing system that will provide lower-cost, scalable versatility for broad MVA vaccine and immunotherapy applications.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>OTHER NOTABLE DEVELOPMENTS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In July 2022, GeoVax announced the publication of a peer-reviewed animal efficacy study of its MVA vectored vaccine against Sudan ebolavirus (SUDV) in <i>Nature Partner Journals (NPJ) Vaccines</i> (accessible <u>here</u>). The anticipated final stage of preclinical testing involving nonhuman primates has recently been completed and results are expected to be discussed during upcoming scientific conferences during the fourth quarter of this year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM"><b>MORE</b></div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In January 2023, GeoVax announced that the US Patent and Trademark Office issued a Notice of Allowance for Patent Application No. 17/000,768 titled, &#8220;<i>Method for Generating a ZIKV Immune Response Utilizing a Recombinant Modified Vaccinia Ankara Vector Encoding the NS1 Protein</i>.&#8221; Preclinical studies demonstrated that a single dose of GEO-ZM02 provided 100% protection against a lethal dose of the Zika virus.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>LEADERSHIP AND CAPITAL RESOURCES STRENGTHENED</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During 2022, GeoVax strengthened its organizational and operational leadership team with appointments to several areas, including Kelly T. McKee, Jr., M.D., M.P.H. as Chief Medical Officer; Jeffrey Welch as Head, Process Development and Manufacturing Operations; John W. Sharkey, Ph.D. as Vice President, Business Development; Mark J. Newman, Ph.D. as full-time Chief Scientific Officer; the appointment of two new members to the GeoVax Board of Directors &#8211; Nicole Lemerond and Jayne Morgan, M.D.; and the appointment of Valerie Montgomery Rice, M.D., FACOG, President and CEO of Morehouse School of Medicine, to serve as a special advisor to the GeoVax Board of Directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During 2022, GeoVax added to its cash resources through offerings of common stock and exercises of warrants with combined net proceeds of approximately $35.4 million. GeoVax&#8217;s cash balances at December 31, 2022 stood at $27.6 million.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FINANCIAL REVIEW</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Net loss for the year ended December 31, 2022, was $14.0 million, as compared to $18.6 million for the year ended December 31, 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Research and development (R&amp;D) expenses were $9.1 million for 2022, as compared to $15.6 million in 2021. Research and development expense for 2021 includes $12.3 million of one-time license fees and other costs related to technology licensing agreements; excluding these costs, research and development expense increased by $5.9 million from 2021 to 2022. The increase during 2022 relates primarily to higher personnel and consulting costs, costs of conducting clinical trials for GEO-CM04S1 and Gedeptin, costs of manufacturing materials for use in clinical trials, and a generally higher level of activity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">General and administrative expenses were $5.0 million for 2022, as compared to $3.6 million in 2021, with the increase primarily attributable to higher personnel and consulting costs, patent costs, investor relations costs, and travel expenses.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">GeoVax reported cash balances of $27.6 million at December 31, 2022, as compared to $11.4 million at December 31, 2021. Contributing to the increase in cash balances were aggregate net proceeds of $27.7 million from equity transactions during January and May 2022, and $7.6 million from the exercise of warrants during August 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Summarized financial information is attached. Further information concerning the Company&#8217;s financial position and results of operations are included in its Annual Report on Form 10-K filed with the Securities and Exchange Commission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CONFERENCE CALL</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Management will host a conference call, scheduled to begin at 4:30 p.m. Eastern Time today, March 23, 2023, to review financial results and provide an update on corporate developments. Following management&#8217;s formal remarks, there will be a question-and-answer session.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 81pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Domestic:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">877-269-7756</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 81pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">International:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">201-689-7817</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td nowrap="true" style="width: 13%; padding: 0px;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Conference&nbsp;ID:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">13736454</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 81pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Webcast:</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><u>GeoVax 2022 Earnings Webcast</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A webcast replay of the call will be available via the same link as the live webcast approximately one hour after the end of the call through June 23, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM"><b>MORE</b></div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>About GeoVax</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world&#8217;s most threatening infectious diseases. The company&#8217;s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin&#174;, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax&#8217;s lead infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine targeting high-risk immunocompromised patient populations. Currently in two Phase 2 clinical trials, GEO-CM04S1 is being evaluated as a COVID-19 vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient. In addition, GEO-CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. GeoVax has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information, visit our website: www.geovax.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Forward-Looking Statements</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>This release contains forward-looking statements regarding GeoVax</i>&#8217;<i>s business plans. The words </i>&#8220;<i>believe,</i>&#8221;<i> </i>&#8220;<i>look forward to,</i>&#8221;<i> </i>&#8220;<i>may,</i>&#8221;<i> </i>&#8220;<i>estimate,</i>&#8221;<i> </i>&#8220;<i>continue,</i>&#8221;<i> </i>&#8220;<i>anticipate,</i>&#8221;<i> </i>&#8220;<i>intend,</i>&#8221;<i> </i>&#8220;<i>should,</i>&#8221;<i> </i>&#8220;<i>plan,</i>&#8221;<i> </i>&#8220;<i>could,</i>&#8221;<i> </i>&#8220;<i>target,</i>&#8221;<i> </i>&#8220;<i>potential,</i>&#8221;<i> </i>&#8220;<i>is likely,</i>&#8221;<i> </i>&#8220;<i>will,</i>&#8221;<i> </i>&#8220;<i>expect</i>&#8221;<i> and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax</i>&#8217;<i>s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax</i>&#8217;<i>s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax</i>&#8217;<i>s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax</i>&#8217;<i>s vaccines will effectively prevent targeted infections in humans, GeoVax</i>&#8217;<i>s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax</i>&#8217;<i>s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.</i>&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investor Relations Contact:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Rich Cockrell</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CG Capital</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">404-736-3838</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>govx@cg.capital</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM"><b>MORE</b></div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FINANCIAL TABLES FOLLOW</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>GEOVAX LABS, INC.</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><b>Condensed Consolidated Statements of Operations Information</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><i>(amounts in thousands, except common share information)</i></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Year Ended</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">December 31,</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Grant revenue</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">81</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">385</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Operating expenses:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="padding-left: 9pt;">Research and development</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9,123</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15,554</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="padding-left: 9pt;">General and administrative</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,987</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3,577</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">14,110</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">19,131</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="padding-left: 9pt;">Loss from operations</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(14,029</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(18,746</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="padding-left: 9pt;">Other income (expense), net</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">7</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">176</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net loss</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(14,021</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(18,570</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Net loss per common share</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(0.83</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">)</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(3.04</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Weighted average shares outstanding</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">16,973,194</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,099,933</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Condensed Consolidated Balance Sheet Information</b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(amounts in thousands, except common share information)</i></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="6" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">December 31,</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Assets:</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-left: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash and cash equivalents</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">27,613</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">11,424</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-left: 9pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Other current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,326</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">205</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-left: 9pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total current assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">28,939</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">11,629</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-left: 9pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property and other assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,409</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">168</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-left: 9pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total assets</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">31,348</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,797</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Liabilities and stockholders&#8217; equity</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-left: 9pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total liabilities</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,748</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7,435</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-left: 9pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stockholders&#8217; equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">26,600</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,362</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-left: 9pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total liabilities and stockholders&#8217; equity</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">31,348</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0); margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">11,797</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-left: 9pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common Shares Outstanding</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">26,334,953</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6,381,541</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>govx-20230323.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/23/2023 10:34:16 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:govx="http://www.govx.com/20230323" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.govx.com/20230323">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="govx-20230323_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="govx-20230323_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="govx-20230323_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.govx.com/20230323/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="govx_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="govx_CommonStockParValue0001PerShareCustomMember" name="CommonStockParValue0001PerShareCustomMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="govx_WarrantsToPurchaseCommonStockCustomMember" name="WarrantsToPurchaseCommonStockCustomMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>govx-20230323_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/23/2023 10:34:16 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.govx.com/20230323/role/statement-document-and-entity-information" xlink:href="govx-20230323.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.govx.com/20230323/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain-default" xlink:type="locator"/>
<link:loc xlink:href="govx-20230323.xsd#govx_CommonStockParValue0001PerShareCustomMember" xlink:label="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="locator"/>
<link:loc xlink:href="govx-20230323.xsd#govx_WarrantsToPurchaseCommonStockCustomMember" xlink:label="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>govx-20230323_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/23/2023 10:34:16 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
<link:label xlink:label="us-gaap_StatementClassOfStockAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
<link:label xlink:label="us-gaap_ClassOfStockDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain-label" xlink:type="arc"/>

<link:loc xlink:href="govx-20230323.xsd#govx_CommonStockParValue0001PerShareCustomMember" xlink:label="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="locator"/>
<link:label xlink:label="govx_CommonStockParValue0001PerShareCustomMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CommonStockParValue0001PerShare Custom [Member]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_CommonStockParValue0001PerShareCustomMember" xlink:to="govx_CommonStockParValue0001PerShareCustomMember-label" xlink:type="arc"/>

<link:loc xlink:href="govx-20230323.xsd#govx_WarrantsToPurchaseCommonStockCustomMember" xlink:label="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="locator"/>
<link:label xlink:label="govx_WarrantsToPurchaseCommonStockCustomMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">WarrantsToPurchaseCommonStock Custom [Member]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:to="govx_WarrantsToPurchaseCommonStockCustomMember-label" xlink:type="arc"/>


</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>govx-20230323_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 3/23/2023 10:34:17 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.govx.com/20230323/role/statement-document-and-entity-information" xlink:href="govx-20230323.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.govx.com/20230323/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
<link:loc xlink:href="govx-20230323.xsd#govx_CommonStockParValue0001PerShareCustomMember" xlink:label="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="locator"/>
<link:loc xlink:href="govx-20230323.xsd#govx_WarrantsToPurchaseCommonStockCustomMember" xlink:label="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="govx_CommonStockParValue0001PerShareCustomMember" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="govx_WarrantsToPurchaseCommonStockCustomMember" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>

<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_[@ A061O8F4 9$     ! P 0 P(#!@
M             /_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$! 0$!
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\( $0@ -0#' P$1  (1 0,1 ?_$ /$   (# 0$  P$!
M      D*  <(!@4"! L! P$  @,! 0$!            !08 ! <# @@!$
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MZS]-M_(7XKEZL]?BO[W]K/-YB7RS^&C]?>[I7R3Z(_K>N%[][5X%O-TU_]H
M" $#  $% /J&/D2_!74WP>"/EOV<OD%'MY=(Q"G/D4OSY$#Y\A@<I(A#ED@H
ME>$W@B'AP12[@<X!LF-3^!0<*.F<.2&%3@CO<JA?:@O!5X7CH>ZH+ 1[.!,]
MNA<#0D4+EA$D'R@0=O/+3GEMKRH(-W+T\@)QU!I:.FMQL$S+?&CU*NKTDX27
M*G'ZF<+/\"V\@LI:G3P6EXBA@JKK5U2J2@*2S<FL1+*T +%RMCA=UY,Q8B/=
M0ITL[J<;X"F63_H>Q8V$50E&BJE<<5]SA=%EEH=GB:)%#MBBPT\;EJPYFL(6
M74\XFJA\93/M=$M6U ((( /BX>N34EAI0="X@P07/S"G*"!UL/OTD ,G/P@9
M&O%###.2 5L&(NU*7:,PP*F*JH>L34]JC%DT"^0KZW72"#6]P+JBAT35 NJ$
MZ.P<ZL6^;RC@ F0A$VK?<CK;8Z::8ZJ 04?!U 7F6^Q388Z(N-.JZH'F" 3)
M%SHQ5EMM+))"0YEILK)(ZK&16>B)!5()/A'*BIR@(9#+O15_/",)MAEQ@@ %
MPGJE%D]1,%@39<_<HM8RU40)(3^776V6W%Z*2I=;2ZBLQDX[4F;<[?H06DQ3
MY6E+J'D]39ZB6?Z.*&I/-#-)Z&DWK#43'2 $FVF([MHI$$QP-Y&?!0,JO.$1
MRW#( =S;9"8(;57:1.IZF _46\!>6Q5T\N+ *(01FP,O%6VOW(0P)VPS00$,
M6OFM^_BJ>P\*_:M;:#TM.]"^M_7G$+I_[+73'G_KSB%TYYUCI+UD;V'TN)_M
MOWN\OE,]!_DJ/2OX![H[SA>GZ=_M?YW@-]O>?__:  @! 0 !!0#Z:UI2C^R@
MQJBJCPW6:L60*Z>Y)U<MZ]Q=TU@.F44^[+QC!ON[LB+QJV=UJU!*A=UK'ME4
M_NO<8_,W^ZAUVJ7("WY:Y<C9(8+[BS:+N.C>;\?I (_P90[5<!\0!)[[J]I$
M[W7O<V]93N%&UD[[,U:Q7VGDE* L>]KG@6W0&;H4U2,T%HZT=>K%M1<<<>6W
M0FSF@G6V$"%E!$U.&H>83%5+5O%K&1S4W5M7#3 +$+4OIK@:9-6S_P"U;PF5
M+[]&&U#'BHL_=SCA[R)>Z%C)*7<9MA.%^80'AL'V8XW:Y6!FYNZSIS3-8-:Q
M,M]@"UB7VT&&4/ 1C#T3PJW-JN]U=@F4D#7/W&.413]*^]T+FK2.<R(>Q<^C
MN*(?G-E0KK4RV*9MX5<VM+BQM-W-H*$CM=#\9CQ[@K(5O96]LCBY((J5GIN&
MTLN^'-E>+,^XBYA9,/W,+);3'KI3-B>4S'8S-C-H<V0Y'*N)6#/;)84M<&+G
M.^62R;/GF#>%70VCS?R?[GC'F.7_ (H=S5C5+L@.-XM-GM.>>Z0AEOOO'/>C
MA9LI3.WTE!XX=9J9G9*-W$#%G28^8?Q$C-;[JARGU=7[IM@BKFT;9/EIK;IB
M3E5$V9\ EMX\CY YYI'NU$N2(U8$P,9V8@&]7.W/=MJ3DC#^8NV_S3CS&?*S
MPW9QBO2SJX[:6;6O(NN;9'HW.[+\I,D^U]C.!,>8KR)?<0=OCJ0PPQYP.P6W
M!;!]/>?V/61N<LPNS0GKHP/A7!+'7N0\#8:>F)V4KEE]JQAW"N:MF43.E3$5
M&ES;*PXRCN+F/W#N$41XKY:2U$L>SO%V32CE7I>EO2=KF9.".*W%=724!+4H
MJ(9>9HJ">05B&;_;88I9 &8$G3<EJX(8M;&,-LQK#I(FI$LEL6LQ]!^6<0]T
M)@2\&MESW ^N&:,5M;^$3@STTC8;;J(T9>(:?*_:DIY#+O&/#_9_JIU]=Q]"
MC1AK9CM1=>WY3D35ZUEO4=VY>(#@G+-O>?CAD%BMF/'/<Y:\W)'&S78D\=E&
M3&R?/V/==F,^OW37(&SB%M2&SM9UM/Y@9%(<R%7/'C7?!B]330S_ (YJ_J^]
M.'PBHQQ+"DTDE9$5[:FK\_\ *3S6A^K+T]AOZ:O??_*3S6E^IGWS/K]%_P A
MZ_OUF]'<Q;_R+^4I>W>W2S_S'_*^5?Z1_P#,.2?_ #]]3L[I/I%Q_P"*?]+^
M$@T)?L(__]H " $" @8_ /TAW33,Q5GZM-V^8&P*:#6 /UL*?RV6W;RU"G]Z
MJG\TM;\S.Y-?>=OFIV[>L9<=2U#_ #1;MZ_1'^&WTL+7^)*/_;/].W9\14#[
MC?TC;\K6,LWNU!_--OR\SE''WW'ST[9G.YG+T3EJ2%F*U4, =!().X "22 !
M)MD](TG+NWB+-+$4U)J8V7'6<81B_*I]@-[)PD69L[DJ]-B;RZ,IGIQ ?\%7
MR&EU#0/]8_83KQ- /NR;*^KZPJ<5HJ6/XWPCS*;"OGZ6-1[>8JX5\P--?GL5
MR29<U!NR] ,?QD*/+C-L.GZ+5<<:E0*/PH&_E6/=LIE:*_=9SYV8C]FQ_C+(
M.")37TA9]-CSM?S9_P 5Q\Q%OS=1KMUU'/SFW:K.>LFU[&US&W8KN.IB/IM^
M5JF97JJ./F:U')9_5,S6TBC%:JCU&96Y; TU(),S4P&. /"U9M'K(!E*1H2R
MJX+,0U:)!@E@$)$&$VP;8<YD,K63J=#Z&(_9L!KG@Y,9VLBTW/GPTV_:FQ&5
MU&ID:YW,S()_Q0Z>9Q8YC0M:H9J@=F+L^9U+H?*5L?B>F5:=/ZT8D/4ZROIG
MY6I9% N60CF56G D[N+,=RB\[X%]DJ]V&9SP_K*H#0?L)>J]![3?:M_$<S.:
M*RM)(:H1NNF%7I8@<)L]/2J:9/+[B(>J1TNP@>ZH(XV-?/9NI6K'VG8L?.2;
M+KOB*L:.DX<2K(0NH]MW-U.GP/K-M$""3E<GHB5PMQ9:"N#'VZS!FZ]G"U_A
M>_\ ^-E_Z5N^>'J'*R-6DA*8<&&I>'&$2!L!A3AOD;?T:WA_5LAEZU&NA-,U
M*:,P<"60,5Q0ZR8FYE$02;:AIL'DJ^*F>--NTGF!@](/R:AXES"@9S,*74'>
M!*4%ZF<E_ND'=:I5JL6J,Q))VDDR2>L_H"MIV>JT*G%&*SUP;_+84-;RU/.9
M4W$P$J1TP,#]3+?O-JN:\/5QE-5 ED PP?MT9B)VO2,<9V6RFA9VB$S5>JB4
MVG\M\;!%8,!>LF^[$NP@&ZV2TS*J E-!B(]IR.VYXEFOZ! %P%A5RL'4J[%*
M4WA8$M4(.W"" !LQ,)D BU7,YFLU3,.TLS$DDG>2=OR:3IM7]S4JC']Q99QY
M54BV7\-Y5L&2I4U>HJW!F(E%('LTT@J-DF=PAA0H.Y&W"I,=< V_]"M^!OU6
MY+4F%:8PP9D[!&V>BRYK6,^F34B<&'&X!^OVE5#T8B1O -UGS>DYU,Y3425"
MX'('U!+*_4&Q'<";4\O1I,U=F"A0"6+$P !MDFZ++F-8U:GE6(]0+C*SN9L2
M(#Q +==J.O:3FES5/+,*DJ"KJ%,XBDG$MW:*L;ID1)MHOC#(+V,"J_0E2]9_
MNZF)#TM;3]*I;:U0 G@NUV]U03Y+:1X)\/T)6E3%6I?"4T P4L;; %63%Y.)
M8!,66GFO$BKG&%RBF(\F*HK,.D*.JV>6OJ@6O3$TV"S3J""8:6#TV!$,(87@
M@M>!4RAUFKE]552<!IJRL!M9&QJ3A]I2 0+Q(F,SIF>2*],W$;&4^JZG>K"\
M>8P019->\2:L^6=@"**TPSDM>B=IU_,87D1""<1N-FY<\N;IVQTQ=-J6;R==
MJ>9IF593!!Z#_P R+C=;,ZO51$U[2FYP:! JT0*JN!]6JJE679B&R MLKI6=
MK!-:HH$@F.<JB RD[7@=M=I(Q"03&6S^3IEZV39F91M--P,1 WE"H)'U9.[Y
M=$JUF IM4*2>-160?M,+-G&4\G,T493NE%%-AU@J">AAQL-/RVE"MF'K,[N7
M*7$*%6X$F "9)@3 &VVGZ>VBHBUZZ4RPJL2,;!9 *WQ,QOMIU>M34M0TWF[-
MKBJU-">)7%(X%1P%LUD5=SE:=<TJ-(&Z5; #&PNYO)-]\"X"U YA$&CU+JJ<
MU6PR+F50QAU,>KM$K>#;7=06F!@RU.JH@0M2O(=@./9<C@7MF<SFJS=W#D4Z
M<G"B F !LF/6;:QDFU+0:M9GT^NKX5)D(ZJ6!6=@8*58"XR#M%O&?@"K R@9
MJE$?5IUPK,%_NJC*R]9MX@UO5EP=T+T).[!VJ[#J4!0=^(BVO^-:=,?$\[6=
M@2 <(YG(H*>*TEO V$[=MGS>:S#U,RQDLQ)8GC)OMJ.3S]5JE;*0%=KV*.K0
MK$WDJ5,$WP0-ULOGLE6-/-4G#*PW$?.#L(-Q$@W&VA^(L[D(SF6<B"(7&NU;
MQVZ6(AT$W&5-^,&K2 =-/RS,E-&!!D&'=P;P[$;#>J@+M!FRTZ:%JC&  )))
MV  7DFV9\,9)Q4UK4:J"OA(*TE!A* :8-1B3S"#A0' 3BQ85=&(<&01<01L(
M/&U/+ZM3[YE1=B)PU0/OWA_?!)^M9LWH>JIIVKO>:5<<ND['@1*H2=Z,0?J"
M9MBU#3W&7.RHO;I-TBHLK?P)!Z+*RL0P,@C:#QM2T37J@IZY3V&0&9@(YM(F
MXEA^\I[S>!$%67)5\O7HS<<7+;RJPN/4S==M*SV8HT.11S%-VBJI.%7!, ;3
M N&^VB9[,3W-\ERZA DA'J/V@-^%@K1O (%]LOXK\*U:%:G4JK7Y98!2X(;$
MC^JR.UY!(()(%VQF[^HDS ?+P.H1LLS^,W8'/4@K5&8,  ?RW!65PHRE6 C"
M"3%U]7/^'*E*ID:Y+A"X4KBO[+'LNE_9(,@0(,2<SXF\39RDM6G3(4*9"8A!
MONQU&'955G:;S-Q\4,I%-\P2R_\ 1;L%>DBG^T ;4].RCCG:@TDK=-(0S-=M
MYAP"=XQ6SW@?5J@0U,7*,@8@T,0I-W,1QC4>U)$&#+4LLV7JY:;JF,)=]I6[
M0/$ -T$VKY$5Q4S]08ZK"Z_"0H4&\(+PI/K'$;M@I9&C*Y9>U5J1<B;SPQ'8
M@WGH!(TOP_H>70Y3*0*Z_9B.4IW. <;MMYA /M@Y7Q9X505JM90:B+ +C9C@
MD 5$C#44WF)V@RR9ZO32L/85EJ//2$)5>IF!Z+.*#86:XL+FCA.T [XB=AD6
M+X3@!V[O/^@?]O\ ?.5[7+Q<OIQ_U<<<=W&Q.MKI9S.\(8JSTG)@TI^^)XV'
M=UJH\W7A^J#"'JNFR_#_ (AW;V<?#HYM\=5UO]7_ )-LG_NS'CAN7CY>*+L4
M8>UAGCV9Z;/_ +8[YW:;\$\J?>_+GCOM_J_\FV3_ -V<R);E\SEXMV+#A[4;
M)]F8WV__ #G?>X[H_=^[C['7ALG^Z.]\SV>;BP].#V.O#Y?DTOXSS</=4Y&/
M^POP8?L[8W\=UEP3CFZ-L[HZ;)W7XCW:+L7K1T8^WU1;/_"N^_&,(YTSBB>S
MCYEVWU9OVX=]LS\$Q\GF-S.1W?\ >;\6#VN&_A:MWG%WC&<6*<6*>UBF^9F9
MOG;:IR.]_!<9Q8<?)Q0)F.Q,1,]'RU",/+Y+W>R>RU\[ 0VU<)8U0L,$)C__
MV@ ( 0,"!C\ _2//SM)/O.H^<V(;5*9/V9;^2#;LUJC]5-OIBW8R^8;W5'SO
M;LZ?5/6R#Z3;LZ54/OK^HV_^GJ?C']&U^D5?Q#]0MV].K#RH?I%NW1S"^ZI^
M9[4<M1K5.<[ *"C7D](! Z23 MF,_GZJC2*!GMD!,(.&FM]W;;M$;[Q8#+9F
MDXW864_,?^"5S6=7FCV5[3>99CRQ8KI^G,W!JAPC\*R?2+&EE7PD^S2IR?.<
M;?-;%F6K!#_:U"/V02?V;8LWJ2+]Q"WI8K\UASJ]>H?O!1Z%GTV'\.#'[3.W
MSM%AR]*RX]Q3\XM^7DZ2]2*/HMV::CR"VP6O46[5)3Y!;MY*BW6BGZ+5,SE<
MC1IY^I--&555AC!#D0!L3%?Q(M374*;?GN*L E2  13V;>R2P!NEK3ELU7IM
MUJW\T'TV_AGB)L/!BZ_2Z^BWY^33,TAO #']@JWG6PHZIIM6A5WQ?^R0K#S&
MW_A9U';ZLPWX3#>CY14S+%JS>J@]9OU#BQNZS=9DYW)RI]A"1=]IKF;IV#HM
M_P"'1BA-]1KD'&_:QZ%!/&+*^>9LQ6X'LI^$&3[Q/584\M02G3X* !Z+'2](
MIBIGY@M&(*WU54>L_'<-ADR!SLQJ34B;X-5E-_V:8@=5H&MW?WU7]5N[ZM5Q
MYI'8!IQ2MQ4XC>=L7WW0=GZ-/5LAFJU.I28!PCL 5-P8@&)5HW7@F=@ME,Y/
MYC+#]#K<WI$CH(^3*:-2:<O2.%HXGM53Y% 7K%EIHL(H  X 7 ?H&GF\LE1.
M#*#YIV>2QJZ;6;+UQ>!)99Z).)>L-Y+)0U>D<QD9@,3/X:FV?LU!/"-MJ^J9
M>H6H4D9G7VUPJ6*E>,"Z^#N,6S.=K,2SL8'U5]E1T >F3M-BE<GN=(!GC:9,
M*L[L5\G@#%Y!LE&C3"4E$  0 . 'R9_.I^\2F</WCV5])%JNLUQBS-1F52;X
M ]9ATLT@G; Z38&K550=DD#Y[?\ M4_Q+^NW,#@TXF9NCC.RS4-/RC9@CVIP
MJ?NW,6'3 '"19<OGLLV7<F,1.)9^T8!7K(CB19JU2H%I*)))N %\SPBS4M/R
M#UP/:)P@]($,T=) ZK5=+S]!J#U@4AB"K2(C% AN (%^PS;4O#V:;M8B5Z62
MXQ]](;J%LWGJFRFA('$[%'E,"VH>)=6JWNQ1-[.Q.)\(WDF!P$&2!8O0T9CE
MQM)<SY80J/.;94TLB328PX+0R7B\7%6!F1>#<00+C9*XTY*N18QB#D%3P883
M$[C,3<8NFCG<JTTW&S>IWJ>!!V^?819M*T?(+64&#49RJW>LURGL@W [6.S:
M+#'&*+XV6J4,Q25Z+""")!%J.0ILS:7GARR),E*G8*D\4)!#;8ZS:MGLM3+:
M=48M=_5DF2&X+/JG9N.Z:V5S#!:>8  )V!U)P@G=BD@=,#?\NI4Z8EP@;\#!
MCZ ;+EP1S:-1@1T,2RGRS'D-CFZV?-.DM-550N+>2QO( F1LVQ?NMF\V-29C
M2ILT8 )P@F)G?%LW2IN0*N<Y?4I0.P'"8@\9-J&9*J*STA4J5#MO&(B=RJ+H
M'"=IM5%%F.H)?3;EL)O]4D@2K#CLN-M+RA<]JLZ$SM2E>JGHO7R+:C1H4QS2
MH+O[3-%Y)VQ.P; +5-42F%S=(K)%V)2P4@QM()!!VB(WV\.>*TOKD!:AXO3)
M4$_WB*5/5;2=,R)Q=X"U(&_%=3'E))/4+:5X;=CW++4E! NDX.;4;K<W3MBR
MT*%)4HJ("@ ".JV3S&5IA*=>25%P#*1) W8@PD;)$[[5<MF*8:@ZP0=X/_-Q
MW&^VIZ1ELW.6K*+P;\)V'[+Q*MQ%X]DA'E6S=90SL+Q$2JJ=Z@':-I).R/D9
MW8!0))-P XFU'6LRN#3LHC<J09=C>U2-H0 #!=+$8MD258 J1!!WV>MD'[O7
M-\ 33)^[[/ND#HLN7U/(MG-/6X5*9Q.HZ1<S ?: /VC;#E,VIK#:A[+CK4P?
M1'38JPD&SZEI:%],?:+R "9P/%X /J/NW[P5;,4ZM*IO&'&/(5V^4"V>RU*I
M5YM2BZB48"2I D[K[:EE:4=X7,XTX%E1;O>!(Z)FU70M=IU:;K3-+$%DA8*P
MR[0RBX&"# \H'=28XK6GY[*OAQ01EJA*H 5-X[2PU^)@<0)VD 3:GE=72HF9
MIC"6"DAHNO'K*W$1$WW;+4=%T7+NR.P))$%HV7>R@/:9FX"X;_@:D%EI0I_Z
M@[0;HE_08L^;S"G!E!$'<YD!?=&(]!BV5\39!,02,>^"MP+1?A93A8[KN-A4
MK"JE:+UPXK^AA<1TF.D"U+-<HIE4.% >L%B3LQ&Z0-@@=)?-5(-8W(N]F_4-
MK'<.DBV>U;4ZS#,9B33/3_:$?5NPJOU9CV3:MH.NMRTIDA&,G"?JW;4;UD.R
M^-A$!LM2=J9]HJ47R8@"?(".FR\U<0&X[)XQOZ)V;K!<0Q</T!\5[OCW8L./
MW?;G[M]OX:<Z*.[$)3R#,$/'W3;\THRQ?<5\][#Z+-WONG/WX>/3@N\]O]/_
M )ELQ\!PX9&/#CPSNF;ICRQT67XUW?G;L48X\G:CT6_T_P#F6S'P'!,#'@QQ
MT3-T[8WQT6_B_=N\]/K^7#VO/9O@G(P;^7$^][7G^3._#L$\]N;A_M;L4].S
MHL<488OG9%FY_=.?-\;)Z</9ME>_]V^'R>7$89B_#@Z/6CRVH_$L./ ,/,YO
MJ[HQ;O1QM3Y,<K",,;(BZ(NB-D;K)S>1\2PB)P\S#-T3VHF8^5 <6/F+?O\
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MUX_Z7_\ GGQE7_++])>4]S7_ '8]MO=GTAYOVSKT_P";^L?Z5]3^7]3DZ/\
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KG",F8B1; T33N59,C$)P3<YI"1B'=;34(E(A(M8EM3E7IW+%>12;IK?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139726870374256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 23, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">GEOVAX LABS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Mar. 23,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">001-39563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">87-0455038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">1900 Lake Park Drive, Suite 380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Smyrna<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">30080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">384-7220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0000832489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=govx_CommonStockParValue0001PerShareCustomMember', window );">CommonStockParValue0001PerShare Custom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GOVX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=govx_WarrantsToPurchaseCommonStockCustomMember', window );">WarrantsToPurchaseCommonStock Custom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to Purchase Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GOVXW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=govx_CommonStockParValue0001PerShareCustomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=govx_CommonStockParValue0001PerShareCustomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=govx_WarrantsToPurchaseCommonStockCustomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=govx_WarrantsToPurchaseCommonStockCustomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>govx20230323_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:govx="http://www.govx.com/20230323"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="govx-20230323.xsd" xlink:type="simple"/>
    <context id="d20238K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-03-23</endDate>
        </period>
    </context>
    <context id="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:CommonStockParValue0001PerShareCustomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-03-23</endDate>
        </period>
    </context>
    <context id="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000832489</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">govx:WarrantsToPurchaseCommonStockCustomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-03-23</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20238K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20238K">0000832489</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20238K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20238K">2023-03-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20238K">GEOVAX LABS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20238K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20238K">001-39563</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20238K">87-0455038</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20238K">1900 Lake Park Drive, Suite 380</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20238K">Smyrna</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20238K">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20238K">30080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20238K">678</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20238K">384-7220</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20238K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20238K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20238K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20238K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">GOVX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001PerShare">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">Warrants to Purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">GOVXW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K_StatementClassOfStockAxis_WarrantsToPurchaseCommonStock">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20238K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M4$L! A0#%     @ &TAX5@=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  ;2'A6=D!^-^X    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M"  ;2'A6F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( !M(>%9Q:MP5[00  ',5   8
M      " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M"  ;2'A6GZ ;\+$"  #B#   #0              @ $P#0  >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( !M(>%:7BKL<P    !,"   +              "
M 0P0  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( !M(>%8ZJJ+G0 $  #P"   /
M              "  ?40  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  ;
M2'A6)!Z;HJT   #X 0  &@              @ %B$@  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  ;2'A699!YDAD!  #/ P  $P
M            @ %'$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"  "1%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="govx20230323_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.govx.com/20230323/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="govx20230323_8k.htm">govx20230323_8k.htm</File>
    <File>ex_492481.htm</File>
    <File>govx-20230323.xsd</File>
    <File>govx-20230323_def.xml</File>
    <File>govx-20230323_lab.xml</File>
    <File>govx-20230323_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "govx20230323_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 25
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "govx-20230323_def.xml"
     ]
    },
    "inline": {
     "local": [
      "govx20230323_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "govx-20230323_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "govx-20230323_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "govx-20230323.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "govx",
   "nsuri": "http://www.govx.com/20230323",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "govx20230323_8k.htm",
      "contextRef": "d20238K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.govx.com/20230323/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "govx20230323_8k.htm",
      "contextRef": "d20238K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "govx_CommonStockParValue0001PerShareCustomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CommonStockParValue0001PerShare Custom [Member]"
       }
      }
     },
     "localname": "CommonStockParValue0001PerShareCustomMember",
     "nsuri": "http://www.govx.com/20230323",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "govx_WarrantsToPurchaseCommonStockCustomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WarrantsToPurchaseCommonStock Custom [Member]"
       }
      }
     },
     "localname": "WarrantsToPurchaseCommonStockCustomMember",
     "nsuri": "http://www.govx.com/20230323",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.govx.com/20230323/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001437749-23-007711-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-23-007711-xbrl.zip
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MO:C/,9PC^/B<H5A!RRC>>5 -O1BM5/R0-Y&9WD,O6,!'CP\\&?\#"U70C?(
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MP0K)3<:N3S-9LDS([XT0,@!%@QA7QV^,.D*Y#LH"L3.[1P(7M3(ZJER2V+B
M\RYL,XCP0)R2R\L2@XM6ZN%YI*FWL;N]O5[9(%,O!02AM-%'12OH*(6Q6)HY
MN^5&&;W9UXXN]"9A9!UT)GHO 3XXLR>;>'[1II!NH/6?!S^5'7L:)SQR$5O5
MW8VM+5K$(J+62^ U"ML.I0R*N-/R5AI?J795 L> 525.D),B<>K:@>H %V0
M#&P6D$.R54^(HVV[9"-,O8IC8\*Q(BL)L"0&#@,K-%72TQ+VU2VB$1@<%@)G
M-P;(Y[E_L],M<CO*,:D:E]IT,Z[_]$!F80T.>#; U; =?RB]")F']H^<I!CQ
MH0EB<H$;\!R'ZE8&W=@33DR9&E$.RQ/B3Z*; #Q3[WH7#-\XD*('',R1WD'L
M1>[0PU\B [L0V6F/LYD*/AV=^9BUP' ._@H!\FH?HD[5Y&V4=_ %/@# 7]&*
MH[X*@$&R#G=>5]<E?R4(M;C7 ^#'LHYWCL4(0G1XU"#V3+)IAAH(0G$6VLZ
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M1NP=*(]6%J/K"^X!K:SS&HCN*HXZ@;2NW[BDG.:L-#N,NY%)Z<"8L4Z>XE2
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M+&.5IE0NP$!H4NKLN5W)6:.V.98H ;# AQ-V$;N8Y!='VC P>5X"7GG&7UD
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M8/^!TW>95MP6L!"G*)*M,)!T1IUN^U;0U-DF*I$J7QKGW^](2;:4R(WL#L4
M Z;(Y^$]=SR>3I=O=T5.OH$V0LE9E(S&$0')52;D9A9]6L;OEM?S>42,93)C
MN9(PBZ2*WE[]^LOE;W'\'B1H9B$CJT=ROW4R WVC"B +I2W+24PF] )_XXL)
M2<;IY%6:O"&+NSCV_)W)4L.W4#""(J1)=RN=BUFTM;9,*7UX>!CYF9'2&]QA
M/*%">AD<H@9OL@[Z8=)@$_K/W>TR[+T'YT)^Z8,GT^F4AM4&*I64KN@7DEE-
M[6,)%$$QHD +WO",+?6>%1@&^&BCOE&_XJ.0--!G8KJ>^N45,WM/!\CI2O&
MS';%U+N_IM5B \U ](O&A:#YZZL&RI635C_VP^O%CIM&\",!$;P#Y$YKS+MC
M6]>K'0KL^+8?[E<Z4)S<=>+G)T9<%2$SQY.+2428M5JLG(4_E"YN8,U<CO%S
M\JMCN5@+R/!BY%" M!U :]DRO0'[@15@2L;A!8/-#1!%B7>%R%[:L?ROKLVM
MXLR&>WN4XI_BAA?[J3BYB"?)"$U']&0-4ZI5CLD&&W_IA^G(M>ZPO(JI5Y&\
M.4=%_P4<(J3-_% 13]=R[%KW"3!'\6$4^]&/A> \]W_(]V=59& N-@1O]O4Y
MP6Z7HT'1/A#\,*Z&YUCN5K9!MMN4YN&4\SY2+(=E60WW@[-M/BFYPYQN<_9/
M9TMHE?%!YO?X,.J:K0TS*94->S126%D*N5;^T;]TT^;-^Q'6)#0%*=/<EZ_O
MMPZTU*H$;068]LL[;+#5L)Y%_@T0-]7_<\Y6(WPW-9!G!KI5/)1/I$!^>Y#7
M</V=GD4&8YI#%>*?Z4@&ZU,=08J0PA_"_\Z;4L.IWB#%8%/ 3O/'4^]QB0AL
M8?'M;$-G$6>*NS# ;CO&?V$?8Y^>N@C[1\3S/GV<?[^WJ(0-WW6OZG R5>,T
MI$.]&H_'V.??U#;:PW<R([\'<V1^,'=)G]C:FW<&LC_E51ASEG.7[Z-:DVI$
M'Z&;52_CGY[;,P;M'%28>5(P:'])J=M$PE;&:L:Q2;3:8=KYH_9G];D)$,:G
M"L^\?<2^*LZB%S BQW+@D[/:VCBT):SSJ^^U<N4L"A]3J< 4P,XT)&$U@YKP
MVVZ.\]XM3-,PBY=$J.P^X#*G*S-TL$?7JBB47%K%ORR8_HOE#C MD@7HY99I
MN';&JN(.BA7HQL'3*.?X6WW&I9DJF)#_L<-_,ZV9M.9>+9SF6[P(+7_ZW#V%
M\!.=I8>/<'S\%U!+ P04    "  ;2'A6Q#6$FY %  !1-0  %0   &=O=G@M
M,C R,S S,C-?9&5F+GAM;-5;76_B.!1]7VG_0S;SG(:4SNP6#3-"M#-"VTY1
M8796^U*9Y )6'9NUG0+_?NWP43K$B?E(E)4J",ZQ?8Y]?7WMJW[\O(B)\P)<
M8$;;;G#1<!V@(8LPG;3=[P.O,^CV>JXC)*(1(HQ"VZ7,_?SIUU\^_N9Y7X$"
M1Q(B9[1TAM.$1L!O6 Q.GW&)B.,Y3?]2_34NFT[0:#6O6L$'IW_O>;H^P?2Y
MI3]&2("C>%"1_FR[4REG+=^?S^<7BQ$G%XQ/5!N-IK]!NVNX?AO);85=\'M_
M]7(+W6MZWDRQP?7UM9^^W4(%S@*J1@/_[_N[03B%&'F8ZD$)-1>!6R(MO&,A
MDNE(%DIPC C]R]O /%WD!9=>,[A8B,C=#ASB(6<$'F'LK!^_/_;V1P)3Z4<X
M]M<8'Q&B"*<M3#F,C40WPZ?[?Z][?K=34RYGR@X$CF<$7/]42A&+$:9>#/$(
M^)'D,MLX,TT< ]7+Q%MU=BQ30S/G)3M5K?$P&8&W[>](OCDME3:^,$8)D:</
M\-MV#'0W7'\FJGN:L)?%1<CBU(,UFLJ5I535PI>@>I%J#L,D?5#NT5/?6"Z5
M8Q@S'J=^X*T$W9JW:2GE>G!#!@U**:98 ^_4SS564RU%S8H$+"0H?[_CD@@+
M]Z9,;*9<0*@)^!%@W7_P[Y5^]%:/JXD#_'2;=GKS9F40- +2=DVO5VR(]KR,
M[XQ)M6RRC:T45C?K6>J]SLP0C0AD,"R"5LM2V2;TE*D).Z9[\!+9WL$$D=5\
M=A8XBZ !4<$(#E47.2.V^[H"-GW@F$6W-+I17B.'5B:N]+7Z"!,L)$=4?D-Q
M%KT\6.GL>BJRYC/&4_,>:+?;90F5?-EED9FL5:W2N7_!!+XEN^'5'M%]2.FL
MAFC1B_1.-<:KR+N 8@&^=+Z=*.(@Q/I+>[C R#4'6Q7/KGI\X$,V-V]_1F15
M'-,5\<#[G+W@U7$LEZ@!7A7;/E/A%OD'SW*7?!ZX1*9Z$CL<D(%;UNLR]V35
M*.E/&37['1.D1%8_.)8J\.VR.$[HVHEDQ0NYN!+Y#1C!H3H*T,F],G2.$<D@
M9P:5R*S/08\&J%67QBWZ], ?QN/,F2T&5\>T)T0"_""^QBIESCR$B3*Z97 Y
M&F*9>1XP04ID->1(7R8.EO&(99EBYOL*1NEV$4X1G8 A3LR#E;Y7W,; )VI0
MOG(VEU-E5S-$E\;-(A==(M>.,O1(&_L7@B89[#+?ESYV7=4A1Z2G5M[B3S"/
MF@%W%+\Q$J/T0BH1W@2A64K2!R+%IB3EZC6"]37NNW7QTV!S]](E2(B'\4"R
M\#GC!&J-KYC_+HW,>Y)BX/^'\;%W//OW?KKD2>\7^D"GVN\C_A<B"30:C4 =
MG =3I+:31$@6WT-&Z'-L]1,)_T!<'YG%D/43KMRB@!T.170/KFPB^WK7V>&A
MP[C:8=MN0]5*[X%;(6$"HK8K>;)UV.LKYN/O^,><Q?G70*SH@E)U420B.+N(
MM_9ZE(ILH[=0<UG%E-C[16;OBRS$-2N9JC.IRY_"*M953A+IU2@++ZN9Q4UL
M=<OL;)H.W-NKG+?,M.I;V\Q93.S4G:I"GWD6H4?N<:?-Z+J040D+>4M2"VJ[
M B;ZX>"!V,GRYUKQW5YRAAV2<JK%S!XK;3_C4N%V>'XY.9F:"G?"\^DJ3O%8
MR+JJJ:P#DD$6*M_75*4IDV0AZ4--)5EEGBST_5Y3?879*@MM?]1;FRG'9:'L
MNM[*<I-B-GMU^?'F2?IR$FDVZNH7BIA3<39ZZA>+Y"?R;#35+PZQR #:"*M?
M)%*4/;115;_(PS;C:*.N?D'(8?E)&XWU"T3RLYLVFNH7@.2D1VT$U2_N*$ZL
MVARFZQIO6.1B;>35+^#(2>;:"*I?Q&&1!=ZYE_-_TJ::??ZT+=<?^I]U5,E_
M4$L#!!0    ( !M(>%8SB+$4V 8   %&   5    9V]V>"TR,#(S,#,R,U]L
M86(N>&ULS9QK;]LV%(:_#]A_X-PO&U!%=MP52-"T"-RT,)8T1NVNPXJAH"7:
M%BKI>!2=./]^)"4[EDWJ9I,:4"2*='3>X_<\$JF+^^;=.@K1 Z%) /%5IW?6
M[2 2>^ '\?RJ\V7L7(\'PV$')0S'/@XA)E>=&#KOWO[\TYM?'.<CB0G%C/AH
M^H0FBU7L$_H>(H)&0!D.D8/Z[CG_USWOHU[WLO_JLO<:C>X<1^P?!O&/2_%C
MBA.">!UQ(O^\ZBP86UZZ[N/CX]EZ2L,SH'.>H]MW-]&=+%QL]=EVA]W@W]UT
MXS;T(/5C7\;V+BXN7+EU&YH$JD">M.?^=7<[]A8DPDX0"U,\44L27"9RY2UX
MF$DG2S\"TD:(OYQ-F"-6.;USI]\[6R=^9VL<A9!\)C,D?G_Y/-0J7K@BPHW)
M7/3I%D])R"N6*1:4S-3[A93F=A-57(@J>J]%%2]4V=C3DL.1!-$R)!WWR#I'
MA ;@W\0G+EB=UD#E8X8I,U'[8>*35C\!?MB>MN[#E*>MF)^[R(DK/DAYTHH_
MD1.3L9_P5-4V*),=EEBIME#$W/*E+$RD*SB)2K7LE+V3EJP9X4/0SEDR!.^@
M_&0S4B3$.YO#@^N30 Q1O7]?B44G7935\S^_W\0L8$]\5,-!O)&3Y5YU=)O3
M:D(Q& #=_Y3%*9QPUZU*-AS:2TD"*^JEPR17$F,YB9TOX\[;5 M]2]7^>>,^
M%Y,O\YING,/4*ZDCBW ]X./ADN4_PXQ"5& 5E'F0?B0N(8T\86-O^=$3IKK7
MZR!1]%834;.]>UE,=UC*H4V?A:+=+NM,@PIN&.OU>_!6$8G9,)X!C>0<C9]M
MR)"12-7X*N$U*2A*:1J)C3;:$4??A#R2^G8!J60NU'7-)CH3/ U)-6QRH<<C
M(].U@XN4;IV4O)]Z2A1&&2=DP@4*J-C=W) $D<)6]U\BH=9*OW-.09D%QONZ
MO6I\SV?;!0U6QC7L="Z7O9:GLGSVX",AW$KWU39"97^,\9#.6CZ3>9 PBF/V
M"4<J'(K"&ET9Y%/9N4)XB9Y5D9!MX4I!8R%4]<8P",/8 [H$*L>;,>,<#F 5
M,_HT %_/1:6]&F%2F-D6-;DB7B)9!@**LE*0J*4%E*JY#@WM- S:AR DGU;1
ME% M58<AC1!Z3F.+%Z&(4LD6L%#8!E7\,-SP"5X/?3[(!;,@?9Y0TOV2^$8H
M:'+:XH++H[Q^>Y24V0NU?3/,S[7O<XN3[)>X8.YIV2F(;<2-(I\M9C+-[0*2
M=SCNXS8&G");H99?=E@9\,5[.H%'_3UN;>0QG#QGLTZ)D!93$R'>'B$*.U5\
MZ'RR0X><_MS3$86'('WD7=A43?@QG.REM [+=B*[J: ]8G3NJK IM,T..R-(
M& [_#I:%ET5%P<=PDTMHG9I4'7'YMBY\"GU5$5-@F#%>Q,GMFA*L(42UN283
MNRE,4R#'%2%FO^=*IZ#, G-/6'E[PM$"8OWEJRZD[C/6O33&'[(*/20%V[@N
MT;H&5>PPUN^O-&",Q .(HE6<7?ZH'J\6QM7LO#*7Z?9GHBBO:A6!8@^ALCG&
M8!A#&'@!"^+Y'9^#T "'"A+T034Q.$QDFH%G1;21M I @750S1-CK1]1(I C
MO'[YR$Z\E$7O9S/E"% >7!,%?4+32'!EQ]N11JDVDN)6X:A@*M1SRQ8LPR19
M$5H+&>TNQX%SD-8Z/FD%_QN*]#ZK62HQT-S(0[P5'_B>>N?32<"4;^KH0NJ.
M.GMI3!,B11#,4._\U^EO:"-O=]S160=5/#'6] G%XDLKXZ=H"JJ9AG)[S7;G
M<ACO=2J&4C6K+59[!:4F&#^B;];>@GM$-&]>%(4U/+)W4QF?46:::"-J_\6+
M0@>AJC6&;RS>1(3..8(?*3RR!1]QECA^TMY9+(QN=&M1F='6O<6-.$K542;?
MPJW%8F.AIF/&F+GF4Q%?3$<^A'BNH$2YO287N1RF2=B*(:%FM?%JKZ#4!,,G
MA $7I3@<\HGF^@^B/Q5HXAJ=!/9RV3K\,UDD=1$7;N' U]D(E?UIP,,,)U-9
M[RIQYA@O)10N"5FR62/9<+J][*NR+[+5W^4S,,'E(,1)<C\;,_!^*+[Q4SF^
M!B^E.8T_C!!ZXHI!*MK^/E!U2Z&V5U89VBU%^57 \L &U!PFLXV+[:\)5K 1
MJOM3#1$^RJQ%W_O=_GE?=EVL^2[N9(@7/WGN$:9_XG!%NMUN;T3H>($I&:P2
M!M$=43S7:KI[#4+J2ACGIK@4E-:"OJ75V..I<2O@6(^/8N\KIN*5]F0"(V[X
M B=DIXXR\FKO7)>[R@+&'\,5%=(N<_6; ,>YN\\;_X0['_B6+[U]7A6D_[D(
M7_,?4$L#!!0    ( !M(>%9O&IX0( 4  "8U   5    9V]V>"TR,#(S,#,R
M,U]P<F4N>&ULW5M=;^(X%'U?:?]#-O.<AI3.SA8-,T*T,T+33E%A=E;[4IG$
M@%4G9FVGP+_?:_.Q5,2)839HL%1!B(_MXY-K^_K>]/W'14J]%\P%85G;CRX:
MOH>SF"4DF[3];X.@,^CV>KXG),H21%F&VW[&_(\??OWE_6]!\!EGF".)$V^T
M](;3/$LPOV$I]OJ,2T2]P&N&E_#7N&QZ4:/5O&I%[[S^?1"H^I1DSRWU,4("
M>\ C$_IGVY]*.6N%X7P^OUB,.+U@? )M-)KA!NVOX:HTD=L*N^"WX:IP"]UK
M>M[4V.CZ^CK4I5NH($5 :#0*_[J_&\13G** 9$J46'$1I"7TS3L6(ZF5K!R"
M9T2H7\$&%JA;0709-*.+A4C\K7"<4?R(QY[Z_O;8>]7CA+TL+F*6:N$;37@"
M"A4"7XE3G,D@87&N+^"I!O!-Y!+&,V8\U?1A2+J/*<?CMJ]:"S8M*1)O#FY(
M+F=@.(*D,XK]<#N&&<<"*FGH'=Q8HQ796L:SHH$7$H.A[FA)6?QJQ*IKL;$G
M@6-%($PP4?U'_URIRV!UJ>6 GT^WNE.P?42VW5$TPK3MFXI7;*@R&<9W5/D?
MV-SA":*K/CL+(@H(&1 U<KI9/Z/>?\]EB$84%Y"K@IZ6)5@F[H&A%<EH S\!
MVR%T4<)NM_@$;/J8$Y;<9LD-S,\26H6X&OFMS/T13XB0'&7R*TJ+Z)7!:F?7
M@\V7SQC7IC10"UR7Y9GDRRY+S&2M:M7._1.A^&N>CC W$MV'U,YJB!:]1.T)
M8[+:G"LH5N!KY]M)$M@6Q?I+K2:1D6L)]E0\NW#YP(=L;M[VC,A3<=0SXH'W
M.7LA*X^ME*@!?BJV?0:.#?V;S$JG?!FX1J;J(78X1@9N1<5U^CG0*.U/X5AB
MG-0F2(VLOG,BP<7LLC3-L_4B4N0\E.)JY#=@E,1$PA'O'@R=$T0+R)E!-3+K
M<ZS4@!.H]NN'RD_G#^-QX9.M!I^.:4^('/.#^!JKU/GD<9R#T2VCR]&0R$+?
MVP2ID=60(Q5O&"S3$2LRQ<+R$ZATNXBG*)M@@Y]8!JM]K[A-,9^ *)\YF\LI
MV-4,94OC9E&*KI%K!PP]4<;^B:)) ;O"\MJUZT*''-$>S+S%%VQ6S8 [BM\8
MB9$.\>0BF" TTR1#3*78W-%<@T:TCO2\6=]^&FRB'%V*A'@8#R2+GPM.]=;X
M$_/?I5$8'ZD&VC+>CU2I.T]JU57'(FBWC_B?B.:XT6A$</P<3!$LRKF0++W'
M!0[$L=5_D/!WQ-7!4PQ9/^>PN B\PZ&*[L&5361WHW,='GN,PT[5]AN^!R6P
M7W&<W*WZ-88R=9A.DX/.=#BV%5,F<-+V)<^WJR7B\5[,[W5#:T0X \$S&<13
M0I--[3%G:7E0BU4%X:#YZH%'/^? [><]LY]K5H)<.B#(C\UP*YF:KLATY,JR
M$>E\UY7*>#2S"*J?\QIC*\*!/HBE9?RDZ\PAEF&?)[ RD_.:*_LC9;:1=@<G
MC5$-<[;FG'?C8U4H20Z=\ZY[W!0Y(+]C)<Z52^*8<DI62KQU20FKU)65++^[
M)$MEELQ*DG<.2F)*R5D)\H>#@I2F_JQ4N790E9(DHYV#YHB_:LYNVLG@B*-:
MGE*UD\(1;]4BA6NGAR/N:E76V$X,1]Q3VP2UG2B.>*J'9<'MI''$6RU/O=M)
MX8B76I+RM]/!$>>T^AT#.SF<\DHMWF:PBY@YXI:6O$5AIX,C?JG%6QL[&8=P
M3Q)H^/G#MD1]J/_ @3O_ E!+ P04    "  ;2'A6I3;9(-80  !]:@  $P
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M#KN7\#!(>*BF/#1K\'!Z6PO,1C4>C!.\6L0G<03ONBS@K(?%'!LW^ML[(C3
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M_)$0$/_G'GO_#U!+ 0(4 Q0    ( !M(>%; @\?"#B4  '$6 0 -
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M>"TR,#(S,#,R,U]P<F4N>&UL4$L! A0#%     @ &TAX5J4VV2#6$   ?6H
M !,              ( !33L  &=O=G@R,#(S,#,R,U\X:RYH=&U02P4&
/  8 !@"$ 0  5$P

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
